These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8472733

  • 1. Endometrioid carcinoma of the ovary. Retrospective study.
    Garzetti GG, Ciavattini A, Goteri G, De Nictolis M, Cignitti M, Tranquilli AL, Romanini C.
    Eur J Gynaecol Oncol; 1993; 14(1):51-5. PubMed ID: 8472733
    [Abstract] [Full Text] [Related]

  • 2. Endometrioid carcinoma of the ovary: retrospective review of 145 cases.
    Kline RC, Wharton JT, Atkinson EN, Burke TW, Gershenson DM, Edwards CL.
    Gynecol Oncol; 1990 Dec; 39(3):337-46. PubMed ID: 2258081
    [Abstract] [Full Text] [Related]

  • 3. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study.
    Bertelsen K.
    Gynecol Oncol; 1990 Aug; 38(2):203-9. PubMed ID: 2167280
    [Abstract] [Full Text] [Related]

  • 4. First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.
    Fujiwara K, Sakuragi N, Suzuki S, Yoshida N, Maehata K, Nishiya M, Koshida T, Sawai H, Aotani E, Kohno I.
    Gynecol Oncol; 2003 Sep; 90(3):637-43. PubMed ID: 13678738
    [Abstract] [Full Text] [Related]

  • 5. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB, Popowich S, Dean E, Robinson C, Lotocki R, Altman AD.
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [Abstract] [Full Text] [Related]

  • 6. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
    Tangir J, Zelterman D, Ma W, Schwartz PE.
    Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
    [Abstract] [Full Text] [Related]

  • 7. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [Abstract] [Full Text] [Related]

  • 8. Clinical remission criteria for epithelial carcinoma of the ovary.
    Morikawa Y, Kawai M, Kano T, Kikkawa F, Oguchi H, Nakashima N, Ishizuka T, Furuhashi Y, Hattori SE, Kuzuya K.
    Gynecol Oncol; 1993 Mar; 48(3):342-8. PubMed ID: 7681806
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 10. Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy.
    Piver MS, Malfetano J, Baker TR, Hempling RE.
    Gynecol Oncol; 1992 Sep 15; 46(3):357-60. PubMed ID: 1526515
    [Abstract] [Full Text] [Related]

  • 11. Carboplatin in combination with epirubicin and cyclophosphamide in patients with advanced ovarian cancer. A phase II study.
    Andersson H, Friberg LG, Horvath G, Johansson O, Akesson M, Westberg R.
    Acta Oncol; 1995 Sep 15; 34(6):821-7. PubMed ID: 7576751
    [Abstract] [Full Text] [Related]

  • 12. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS.
    Gynecol Oncol; 2002 May 15; 85(2):351-5. PubMed ID: 11972399
    [Abstract] [Full Text] [Related]

  • 13. Uterine papillary serous carcinoma. A clinical study.
    Gitsch G, Friedlander ML, Wain GV, Hacker NF.
    Cancer; 1995 May 01; 75(9):2239-43. PubMed ID: 7712431
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy in radically operated advanced ovarian cancer.
    Petru E, Pickel H, Lahousen M, Boike G, Heydarfadai M.
    Cancer Treat Rev; 1990 Sep 01; 17(2-3):329-34. PubMed ID: 2272048
    [No Abstract] [Full Text] [Related]

  • 15. High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
    Somlo G, Doroshow JH, Forman SJ, Leong LA, Margolin KA, Morgan RJ, Raschko JW, Akman SA, Ahn C, Sniecinski I.
    Cancer; 1994 Jan 01; 73(1):125-34. PubMed ID: 7903906
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.
    Grem J, O'Dwyer P, Elson P, Simon N, Trump D, Frontiera M, Falkson G, Vogl S.
    J Clin Oncol; 1991 Oct 01; 9(10):1793-800. PubMed ID: 1919629
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of carboplatin and cyclophosphamide combination chemotherapy for the treatment of advanced ovarian cancer.
    Teeling M, Carney DN.
    Eur J Gynaecol Oncol; 1990 Oct 01; 11(3):219-24. PubMed ID: 2209642
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S, Norwegian Lung Cancer Study Group.
    J Clin Oncol; 2002 Dec 15; 20(24):4665-72. PubMed ID: 12488411
    [Abstract] [Full Text] [Related]

  • 19. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan 15; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

  • 20. Carboplatin/cyclophosphamide combination chemotherapy for advanced ovarian cancer.
    Teeling M, Hayes Y, Fitzmaurice B, McGing P, Carney DN.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 2):102-6. PubMed ID: 1411620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.